LEQVIO and LDL-C: Time to take control of Lipid management

Posted Wednesday 01 May 2024 | Novartis

Presented by Dr. Greg Stammer (cardiologist).

After this meeting, attendees will be able to:

• Recognise the importance of LDL-C in atherosclerotic cardiovascular disease (ASCVD)
• Discuss the benefits of LEQVIO for both patients and HCPs
• Identify patients suitable for LEQVIO in clinical practice
• Implement the shared-care management of patients prescribed LEQVIO

Arrival and registration from 6.30pm, for a 7pm start.

For any questions please contact Jayne Owen on 0449 564 365 or jayne.owen@novartis.com